NCT06169397 - An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions

Pulmonary Sarcoidosis

Interventions

DRUG

XTMAB-16

XTMAB-16 infusion

Trial Locations (11)

Xentria Investigative Site, Philadelphia

Xentria Investigative Site, Greenville

Xentria Investigative Site, Cincinnati

Xentria Investigative Site, Chicago

Xentria Investigative Site, Denver

Xentria Investigative Site, Prague

Xentria Investigative Site, Bielsk Podlaski

University Hospitals Coventry and Warwickshire NHS Trust, Coventry

King's College Hospital NHS Foundation Trust, London

Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich

NHS Tayside, Perth

All Listed Sponsors

lead

Xentria, Inc.

INDUSTRY